- Home
- SCLX vs JMG Comparison
SCLX vs JMG Comparison
Compare SCLX & JMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCLX | JMG |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.0M | 97.8M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | SCLX | JMG |
|---|---|---|
| Price | $11.37 | $6.75 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 75.9K | ★ 552.0K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | ★ $40,360,000.00 | $30,782,659.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $749.70 | N/A |
| P/E Ratio | ★ N/A | $57.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.60 | $4.23 |
| 52 Week High | $34.27 | $9.60 |
Technical Indicators
Market Signals| Indicator | SCLX | JMG |
|---|---|---|
| Relative Strength Index (RSI) | 31.18 | N/A |
| Support Level | $11.10 | N/A |
| Resistance Level | $13.83 | N/A |
| Average True Range (ATR) | 0.99 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 8.28 | 0.00 |
Price Performance
Historical ComparisonAbout SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.